Analysis of methods commonly used for glycopeptide and oxazolidinone susceptibility testing in Enterococcus faecium isolates

Journal of Medical Microbiology

Volumn 59, Issue 6, 2010, Pages 672-678

  Raponi, Giammarco ^a   Ghezzi, Maria Cristina ^a   Gherardi, Giovanni ^b   Lorino, Giulia ^a   Dicuonzo, Giordano ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; RNA 23S; TEICOPLANIN; VANCOMYCIN; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; GLYCOPEPTIDE; LIGASE; OXAZOLIDINONE DERIVATIVE; VANA LIGASE, BACTERIA; VANB PROTEIN, ENTEROCOCCUS;

ANALYSIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BROTH DILUTION; DISK DIFFUSION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; EPSILOMETER TEST; GENE MUTATION; LABORATORY TEST; NONHUMAN; PHENOTYPE; PHOENIX; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TECHNIQUE; VANA GENE; VANB GENE; VITEK 2; DRUG EFFECT; EVALUATION; GENETICS; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; DNA, BACTERIAL; ENTEROCOCCUS FAECIUM; GLYCOPEPTIDES; HUMANS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, RIBOSOMAL, 23S; TEICOPLANIN; VANCOMYCIN;

EID: 77952983015     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.016444-0     Document Type: Article

References (26)

1. Abele-Horn, M., Hommers, L., Trabold, R. & Frosch, M. (2006). Validation of VITEK 2 version 4.01 software for detection, identification, and classification of glycopeptides-resistant enterococci. J Clin Microbiol 44, 71-76. (Pubitemid 43100582)
2. Alam, M. R., Donabedian, S., Brown, W., Gordon, J., Chow, J. W., Zervos, M. J. & Hershberger, E. (2001). Heteroresistance to vancomycin in Enterococcus faecium. J Clin Microbiol 39, 3379-3381.
3. Biedenbach, D. J., Moet, G. J. & Jones, R. N. (2004). Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 50, 59-69.
4. Bonora, M. G., Solbiati, M., Stepan, E., Zorzi, A., Luzzani, A., Catania, M. R. & Fontana, R. (2006). Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage. J Clin Microbiol 44, 1153-1155.
5. Clark, N. C., Cooksey, R. C., Hill, B. C., Swenson, J. M. & Tenover, F. C. (1993). Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother 37, 2311-2317.
6. CLSI (2006). Performance Standards for Antimicrobial Susceptibility Tests; Approved Standard, 9th edn, M2-A9. Wayne, PA: Clinical and Laboratory Standards Institute.
7. CLSI (2007). Performance Standards for Antimicrobial Susceptibility Testing; 17th Informational Supplement, M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute.
8. Deshpande, L. M., Fritsche, T. R., Moet, G. J., Biedenbach, D. J. & Jones, R. N. (2007). Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 58, 163-170. (Pubitemid 46856806)
9. Donabedian, S., Hershberger, E., Thal, L. A., Chow, J.W., Clewell, D. B., Robinson-Dunn, B. & Zervos, M. J. (2000). PCR fragment length polymorphism analysis of vancomycin-resistant Enterococcus faecium. J ClinMicrobiol 38, 2885-2888. (Pubitemid 30640567)
10. Falagas, M. E. & Vardakas, K. Z. (2008). Benefit-risk assessment of linezolid for serious Gram-positive bacterial infections. Drug Saf 31, 753-768.
11. Garcia-Garrote, F., Cercenado, E. & Bouza, E. (2000). Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. J Clin Microbiol 38, 2108-2111. (Pubitemid 30414323)
12. Gonzales, R. D., Schreckenberger, P. C., Graham, M. B., Kelkar, S., DenBesten, K. & Quinn, J. P. (2001). Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357, 1179. (Pubitemid 32378693)
13. Jones, R. N., Fritsche, T. R., Sader, H. S. & Ross, J. E. (2007). LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centres). Diagn Microbiol Infect Dis 59, 309-317. (Pubitemid 350016703)
14. Kobayashi, I., Muraoka, H., Iyoda, T., Nishida, M., Hasegawa, M. & Yamaguchi, K. (2004). Antimicrobial susceptibility testing of vancomycin-resistant Enterococcus by the Vitek system, and comparison with two NCCLS reference methods. J Med Microbiol 53, 1229-1232. (Pubitemid 40052478)
15. Lee, W. G., Huh, J. Y., Cho, S. R. & Lim, Y. A. (2004). Reduction in glycopeptide resistance in vancomycin-resistant enterococci as a result of vanA cluster rearrangements. Antimicrob Agents Chemother 48, 1379-1381.
16. Linden, P. K. (2002). Treatment options for vancomycin-resistant enterococcal infections. Drugs 62, 425-441. (Pubitemid 34211023)
17. Marshall, S. H., Donskey, C. J., Hutton-Thomas, R., Salata, R. A. & Rice, L. B. (2002). Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 46, 3334-3336.
18. NNIS (2001). National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 29, 404-421.
19. Park, I. J., Lee, W. G., Shin, J. H., Lee, K. W. & Woo, G. J. (2008). VanB phenotype-vanA genotype Enterococcus faecium with heterogeneous expression of teicoplanin resistance. J Clin Microbiol 46, 3091-3093.
20. Pendle, S., Jefts, P., Olma, T., Su, Y., Gilroy, N. & Gilbert, G. L. (2008). Difficulties in detection and identification of Enterococcus faecium with low-level inducible resistance to vancomycin, during a hospital outbreak. Clin Microbiol Infect 14, 853-857.
21. Rice, L. B., Hutton-Thomas, R., Lakticova, V., Helfand, M. S. & Donskey, C. J. (2004). b-Lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci. J Infect Dis 189, 1113-1118. (Pubitemid 38373105)
22. Ruggero, K. A., Schroeder, L. K., Schreckenberger, P. C., Mankin, A. S. & Qiunn, J. P. (2003). Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs. Diagn Microbiol Infect Dis 47, 511-513.
23. Scheetz, M. H., Qi, C., Noskin, G. A, Warren, J. R., Postelnick, M. J., Malczynski, M., Huang, J. & Zembower, T. R. (2006). The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci. Diagn Microbiol Infect Dis 56, 407-413. (Pubitemid 44869004)
24. Tenover, F. C., Williams, P. P., Stocker, S., Thompson, A., Clark, L. A., Limbago, B., Carey, R. B., Poppe, S. M., Shinabarger, D. & McGowan, J. E., Jr (2007). Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci. J Clin Microbiol 45, 2917-2922.
25. Thal, L.-A., Donabedian, S., Robinson-Dunn, B., Chow, J. W., Dembry, L., Clewell, D. B., Alshab, D. & Zervos, M. J. (1998). Molecular analysis of glycopeptide-resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period. J Clin Microbiol 36, 3303-3308. (Pubitemid 28476183)
26. van den Braak, N., Goessens, W., van Belkum, A., Verbrugh, H. A. & Endtz, H. P. (2001). Accuracy of the VITEK 2 system to detect glycopeptides resistance in enterococci. J Clin Microbiol 39, 351-353. (Pubitemid 32059618)